Clinical trial
Novel Biomarkers of Preeclampsia: Aquaporin, Fatty Acid, and S100B
NCT03567551 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Novel Biomarkers of Preeclampsia: Aquaporin, Fatty Acid, and S100B
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 15, 2017
- Completion date
- September 15, 2021
- Enrollment
- 126 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
preeclampsia